FDA Approves Unknown Drug — LUPIN LTD

# FDA Approves Lupin Ltd's Generic Drug Application Lupin Ltd has received FDA approval for generic drug application ANDA091040, expanding the company's portfolio in the competitive U.S. generic pharmaceuticals market and positioning it to capture market share as patent protections expire on the reference branded product. The approval strengthens Lupin's position as a key player in affordable generic medications and is expected to contribute to revenue growth in the company's U.S. operations.